Fortress Biotech, Inc. (FBIOP) Operating income 2016–2025
Fortress Biotech, Inc. (FBIOP) annual operating income history from SEC filings — each fiscal year as reported.
-$70.2MFY2025 · since FY2016: -$65.7M → -$70.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.2M | +36.4% |
| FY2024 | -$110.4M | +22.5% |
| FY2023 | -$142.3M | +30.1% |
| FY2022 | -$203.6M | -8.0% |
| FY2021 | -$188.5M | -100.0% |
| FY2020 | -$94.3M | +14.9% |
| FY2019 | -$110.8M | +7.6% |
| FY2018 | -$120.0M | -33.6% |
| FY2017 | -$89.8M | -36.7% |
| FY2016 | -$65.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net incomeFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating marginFBIOP Operating cash flowFBIOP Free cash flowFBIOP Capital expendituresFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Total liabilitiesFBIOP Shareholders’ equityFBIOP overview →